Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T67102 | ||||
Target Name | Cathepsin D (CTSD) | ||||
Type of Target |
Clinical trial |
||||
Drug Potency against Target | CI-992 | Drug Info | IC50 = 1250 nM | [1] | |
Grassystatin a | Drug Info | IC50 = 1000 nM | [4] | ||
GRL-7234 | Drug Info | Ki = 41 nM | [2] | ||
KNI-10006 | Drug Info | Ki = 2 nM | [3] | ||
References | |||||
REF 1 | Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors. J Med Chem. 1992 Jul 10;35(14):2562-72. | ||||
REF 2 | Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands. J Med Chem. 2007 May 17;50(10):2399-407. | ||||
REF 3 | alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases. Bioorg Med Chem. 2009 Aug 15;17(16):5933-49. | ||||
REF 4 | Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation. J Med Chem. 2009 Sep 24;52(18):5732-47. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.